RICCI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 5.902
AS - Asia 3.846
EU - Europa 3.134
SA - Sud America 773
AF - Africa 78
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.766
Nazione #
US - Stati Uniti d'America 5.739
SG - Singapore 2.037
CN - Cina 915
IT - Italia 831
IE - Irlanda 681
BR - Brasile 634
SE - Svezia 445
VN - Vietnam 294
DE - Germania 221
GB - Regno Unito 170
TR - Turchia 144
UA - Ucraina 143
RU - Federazione Russa 135
FI - Finlandia 123
FR - Francia 102
IN - India 95
HK - Hong Kong 94
CA - Canada 92
AR - Argentina 57
MX - Messico 46
AT - Austria 44
PL - Polonia 44
NL - Olanda 39
KR - Corea 37
ZA - Sudafrica 37
JP - Giappone 36
BD - Bangladesh 32
AU - Australia 23
ID - Indonesia 21
CZ - Repubblica Ceca 20
BE - Belgio 19
IQ - Iraq 19
EC - Ecuador 18
LT - Lituania 18
EE - Estonia 17
ES - Italia 17
RS - Serbia 17
CL - Cile 14
CO - Colombia 13
IL - Israele 10
PE - Perù 10
PK - Pakistan 10
RO - Romania 10
UZ - Uzbekistan 10
IR - Iran 9
MA - Marocco 9
MY - Malesia 9
PY - Paraguay 9
PH - Filippine 8
VE - Venezuela 8
DK - Danimarca 7
DZ - Algeria 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
JO - Giordania 6
SA - Arabia Saudita 6
TH - Thailandia 6
UY - Uruguay 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
EG - Egitto 5
NP - Nepal 5
CH - Svizzera 4
EU - Europa 4
GE - Georgia 4
GY - Guiana 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
TN - Tunisia 4
TW - Taiwan 4
BG - Bulgaria 3
ET - Etiopia 3
GT - Guatemala 3
HU - Ungheria 3
KH - Cambogia 3
SI - Slovenia 3
AL - Albania 2
BH - Bahrain 2
BW - Botswana 2
CY - Cipro 2
JM - Giamaica 2
KY - Cayman, isole 2
LB - Libano 2
PA - Panama 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
GN - Guinea 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
LI - Liechtenstein 1
Totale 13.752
Città #
Singapore 1.476
Chandler 784
Dublin 662
Dallas 615
Ashburn 469
Jacksonville 313
Beijing 304
Princeton 267
Los Angeles 223
Santa Clara 217
The Dalles 155
Altamura 126
New York 102
Wilmington 97
Ho Chi Minh City 94
Ann Arbor 88
Hong Kong 85
Redondo Beach 85
Buffalo 82
Pescara 82
Munich 79
Hefei 71
São Paulo 71
Tongling 71
Nanjing 67
Izmir 62
Hanoi 54
Dearborn 53
Lappeenranta 53
Boardman 52
Dong Ket 50
Chieti 48
London 42
Washington 42
Montreal 40
Nuremberg 39
Teramo 39
Warsaw 39
Seattle 37
Castignano 36
Denver 36
Brooklyn 35
Helsinki 35
Rome 34
Tokyo 34
Cambridge 30
Chicago 30
Houston 30
Southend 30
Woodbridge 28
Johannesburg 27
Milan 27
Vienna 23
Amsterdam 22
Orem 22
Rio de Janeiro 22
Atlanta 21
San Francisco 20
Seoul 20
Boston 19
Brussels 19
Council Bluffs 19
Nanchang 19
Poplar 19
Stockholm 19
Toronto 19
Turku 19
Frankfurt am Main 18
Chennai 17
Mexico City 17
Camerino 16
Curitiba 15
Manchester 15
Norwalk 14
Phoenix 14
Brno 13
Falls Church 13
Guangzhou 13
Spoltore 13
Ankara 12
Brasília 12
Hebei 12
Xi'an 12
Brisbane 11
Campinas 11
Shanghai 11
Dhaka 10
Haiphong 10
Hải Dương 10
Querétaro 10
Redwood City 10
Romola 10
Santiago 10
Tianjin 10
Belo Horizonte 9
Charlotte 9
Istanbul 9
Kunming 9
Melbourne 9
Mumbai 9
Totale 8.442
Nome #
Athlete’s Heart: A Cardiovascular Step-By-Step Multimodality Approach 198
Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia 179
Role and importance of ultrasound lung comets in acute cardiac care 158
Cardiac magnetic resonance for risk stratification of sudden cardiac death 132
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 130
Cardiovascular risk in non-alcoholic fatty liver disease: Mechanisms and therapeutic implications 126
Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis 125
Late Thrombosis After Double Versus Single Drug-Eluting Stent in the Treatment of Coronary Bifurcations : a meta-analysis of randomized and observational Studies. 123
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 123
Grading of aortic stenosis severity: a head-to-head comparison between cardiac magnetic resonance imaging and echocardiography 121
ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis 120
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion 117
Lung ultrasonography: a practical guide for cardiologists 115
Recommendations for Physical Inactivity and Sedentary Behavior During the Coronavirus Disease (COVID-19) Pandemic 112
Beta-blocker therapy and risk of vascular dementia: A population-based prospective study 109
Extrapulmonary sarcoidosis: A chameleon disease at imaging 109
Prevalence and Clinical Relevance of Extracardiac Findings in Cardiovascular Magnetic Resonance Imaging 108
Cardiovascular morbidity and mortality related to orthostatic hypotension: A meta-analysis of prospective observational studies 106
Isolated creatine kinase-MB rise with normal cardiac troponins: a strange occurrence with difficult interpretation 105
Ecocardiografia nella stenosi valvolare aortica degenerativa 105
Aliased Flow Signal Planimetry by Cardiovascular Magnetic Resonance Imaging for Grading Aortic Stenosis Severity: A Prospective Pilot Study 104
The Length and Number of Sedentary Bouts Predict Fibrinogen Levels in Postmenopausal Women 103
Orthostatic hypotension: Epidemiology, prognosis, and treatment 102
Hospital admissions for orthostatic hypotension and syncope in later life: Insights from the Malmö Preventive Project 101
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 101
Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension 101
The systolic blood pressure vs oxygen consumption slope at the cardiopulmonary exercise test predicts carotid atherosclerosis 100
The legacy of ISCHEMIA 100
Cardiovascular biomarkers predict fragility fractures in older adults 100
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 99
Right heart-pulmonary circulation unit and cardiac resynchronization therapy 98
Proteomic Profiling for Cardiovascular Biomarker Discovery in Orthostatic Hypotension 98
Special Article - The role of hand-held ultrasound for cardiopulmonary assessment during a pandemic 97
Clinical Features and Diagnosis of Cardiac Sarcoidosis 96
Diagnostic and Prognostic Value of Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis 94
Athlete’s Heart: Diagnostic Challenges and Future Perspectives 94
Relations between FANS, PPI and atrial fibrillation 94
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 93
The multi-modality cardiac imaging approach to cardiac sarcoidosis 92
Markers of cardiovascular autonomic dysfunction predict COPD in middle-aged subjects 92
Prognostic Significance of Cardiac Amyloidosis in Patients With Aortic Stenosis: A Systematic Review and Meta-Analysis 92
'The Digital Cardiologist': How Technology Is Changing the Paradigm of Cardiology Training 91
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 91
Organization and Activity of Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging 90
Orthostatic Hypertension: Critical Appraisal of an Overlooked Condition 90
Morbidity and mortality related to orthostatic hypotension: results of a meta-analysis of non-randomized observational studies. 89
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 89
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 89
Ultrasound imaging of abdominal sarcoidosis: State of the art 89
Cardiovascular Magnetic Resonance in Patients with Cardiac Electronic Devices: Evidence from a Multicenter Study 88
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 88
Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies 88
N-Terminal Prosomatostatin and Risk of Vascular Dementia 88
A highly-detailed anatomical study of normal pericardial structures as revealed by in-vivo computed tomography and magnetic resonance images and ex-vivo novel 3D reconstructions from Visible Human Server 88
Prognostic Significance of Chest Imaging by LUS and CT in COVID-19 Inpatients: The ECOVID Multicenter Study 88
Diagnostic and therapeutic approach to the ACS patient 88
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 87
Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome 87
Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura 87
International Impact of COVID-19 on the Diagnosis of Heart Disease 87
In complex coronary bifurcations, should a dedicated stent be better than a dedicated approach? 86
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes 85
Selection of the Optimal Candidate to MitraClip for Secondary Mitral Regurgitation: Beyond Mitral Valve Morphology 85
Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy 84
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis 83
Left Ventricular Size Predicts Clinical Benefit After Percutaneous Mitral Valve Repair for Secondary Mitral Regurgitation: A Systematic Review and Meta-Regression Analysis 83
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies 83
Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World: The INCAPS-COVID Study 83
Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies 82
Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study 82
Clinical Features, Histopathology and Differential Diagnosis of Sarcoidosis 82
P1588Beta-blocker therapy and risk of dementia: a population-based prospective study 81
Orthostatic hypotension and cardiovascular risk 80
Cardiovascular magnetic resonance reference values of mitral and tricuspid annular dimensions: the UK Biobank cohort 80
Management of Aortic Stenosis: A Systematic Review of Clinical Practice Guidelines and Recommendations 80
Approach to COVID-19 in older adults and indications for improving the outcomes 80
Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations 79
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 79
Cerebral Oximetry in Syncope and Syndromes of Orthostatic Intolerance 78
CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification 78
Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem 78
Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study 77
The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury 75
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 74
Management of hyperuricemia and gout in obese patients undergoing bariatric surgery 74
Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome 73
Cardiac magnetic resonance imaging of myocarditis and pericarditis following COVID-19 vaccination: a multicenter collection of 27 cases 72
ECG Patterns of Occlusion Myocardial Infarction: A Narrative Review 72
Classical and Delayed Orthostatic Hypotension in Patients With Unexplained Syncope and Severe Orthostatic Intolerance 71
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: The PROVE-HF study 71
Authors’ Reply to Kindermann et al.’s Comment on: “Athlete’s Heart: Diagnostic Challenges and Future Perspectives” 71
Cardiovascular Autonomic Dysfunction Is the Most Common Cause of Syncope in Paced Patients 70
Vieussens’ ring coronary collateral circulation: a natural bypass history 70
A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience 69
Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients 69
Minimally aggressive treatment of spontaneous coronary artery dissections. 67
Oral anticoagulants in coronary heart disease (Section IV): Position paper of the ESC working group on thrombosis – Task force on anticoagulants in heart disease 67
Massive necrotizing myocarditis in a young patient with idiopathic hypereosinophilic syndrome 67
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation 66
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis 66
Totale 9.306
Categoria #
all - tutte 71.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 0 110 52 21 36 26 45 74
2021/2022807 23 39 18 108 87 18 21 54 49 26 78 286
2022/20232.296 222 369 171 193 193 395 127 175 270 45 92 44
2023/20241.491 114 31 112 47 128 357 284 86 48 68 70 146
2024/20253.874 200 748 508 179 106 140 257 169 457 274 359 477
2025/20264.237 671 367 1.096 994 887 222 0 0 0 0 0 0
Totale 14.698